Abstract
Vanilloid receptor 1 (TRPV1) has been proposed to be the principal heat-responsive channel for nociceptive neurons. The skin of both rat and mouse receives major projections from primary sensory afferents that bind the plant lectin isolectin B4 (IB4). The majority of IB4-positive neurons are known to be heat-responsive nociceptors. Previous studies suggested that, unlike rat, mouse IB4-positive cutaneous afferents did not express TRPV1 immunoreactivity. Here, multiple antisera were used to confirm that mouse and rat have different distributions of TRPV1 and that TRPV1 immunoreactivity is absent in heat-sensitive nociceptors. Intracellular recording in TRPV1-/- mice was then used to confirm that TRPV1 was not required for detecting noxious heat. TRPV1-/- mice had more heat-sensitive neurons, and these neurons had normal temperature thresholds and response properties. Moreover, in TRPV1-/- mice, 82% of heat-responsive neurons did not express immunoreactivity for TRPV2, another putative noxious heat channel.
Introduction
Sensory neurons are a heterogeneous cell population that responds to a broad range of stimuli. Noxious heat sensations have been proposed to be detected by two vanilloid receptors; TRPV1 (VR1) is thought to respond to temperatures above 43°C (Caterina et al., 2000), whereas a related family member, TRPV2 (VRL1), has been proposed to respond to temperatures above 52°C (Caterina et al., 1999). TRPV1 is a nonselective cation channel expressed by primary sensory neurons that is activated by capsaicin, low pH (pH <6), and heat (Caterina et al., 1997; Davis et al., 2000). TRPV1 is found primarily in small-diameter dorsal root ganglion (DRG) neurons and is expressed by both peptidergic and non-peptidergic primary afferents. TRPV2 does not respond to capsaicin and appears to be more widely expressed, being found in all sizes of sensory neurons (Caterina et al., 1999; Ma, 2001). More recently, a third family member has been identified (TRPV3) that has reported temperature thresholds from 23 to 39°C and is expressed in the skin as well as the central and peripheral nervous systems (Peier et al., 2002; Smith et al., 2002; Xu et al., 2002). A fourth heat-sensitive TRP channel, TRPV4, has been isolated, but its response properties suggest it is not involved in nociception, detecting non-noxious warm temperatures (Guler et al., 2002; Watanabe et al., 2002).
The majority of neurons that respond to noxious heat fall into two classes of nociceptive neurons distinguished by their growth factor dependence. NGF-dependent nociceptors express tyrosine kinase receptor A (TrkA), calcitonin gene-related peptide (CGRP), and substance P (SP) (Averill et al., 1995; Fundin et al., 1997; Mendell et al., 1999). Glial cell line-derived neurotrophic factor (GDNF)-dependent nociceptors typically lack neuropeptides (e.g., CGRP and SP) and bind isolectin B4 (IB4) (Molliver et al., 1997; Bennett et al., 1998). In a recent analysis of GDNF-overexpressing mice (Zwick et al., 2002), we found an increased number of IB4-positive neurons. Because these neurons are heat sensitive (Stucky and Lewin, 1999; Dirajlal et al., 2003), an increase in the number of TRPV1-positive neurons was also expected in these animals. However, no increase in the number of TRPV1 neurons was observed, and analysis of wild-type mice found that only 6% of mouse DRG neurons were positive for both IB4 and TRPV1 (Zwick et al., 2002). This was in sharp contrast to studies in rat that found that >50% of IB4-positive neurons also express TRPV1 (Guo et al., 1999).
These observations raised interesting questions concerning the importance of TRPV1 for detection of noxious heat and the extent to which results from one rodent species could be generalized to a different species regarding the neurochemistry of nociceptors. To more thoroughly analyze these issues, we obtained antibodies that were specific for the mouse and rat forms of TRPV1 to insure that the previous results from our laboratory were not attributable to antibody specificity issues. In addition, intracellular physiology recordings were made from primary afferents in TRPV1-/- mice to determine whether deficits in heat responsiveness could be detected.
Materials and Methods
Animals. Male and female Sprague Dawley rats, Long-Evans rats, BALB/c mice, and C3H/Bl6 mice 2-4 months of age were purchased from Harlan (Indianapolis, IN). Mice were anesthetized deeply with 2.5% avertin (2,2,2-tribromoethanol and tert-amyl alcohol diluted in 0.9% saline) and perfused transcardially with 4% paraformaldehyde in 0.1 m phosphate buffer (PB). Both strains of rat were anesthetized with sodium pentobarbital (40 mg/kg, i.p.) and perfused transcardially with 0.9% saline solution, followed by 4% paraformaldehyde in 0.1 m PB. These studies were performed in accordance with the guidelines of the University of Pittsburgh Institutional Animal Care and Use Committee and the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Immunolabeling and histochemical procedures for IB4/TRPV1 colabeling. Dorsal root ganglia (DRGs) (L4/L5) were removed, immersed in 4% paraformaldehyde for 1 hr, embedded in 10% gelatin in 0.1 m PB that was also fixed in 4% paraformaldehyde until firm, and then placed in 25% sucrose in 0.1 m PB overnight at 4°C. Sections were cut at 25 μm on a sliding microtome, blocked 1 hr at room temperature in 5% NGS and 0.25% Triton X-100, and incubated overnight in primary antibody at room temperature. Antibodies recognizing the following antigens were used: a rabbit antibody against the N terminus of the rat sequence of TRPV1 (RASLDSEESESPPQENSC), designated TRPV1R (diluted 1:2000; Neuromics, Minneapolis, MN), and a guinea pig antibody against the C terminus of the mouse sequence of TRPV1 (EDAEVFKDSMAPGEK), designated TRPV1M (diluted 1:600; provided by Dr. David Julius, University of California at San Francisco, San Francisco, CA). The lectin IB4 conjugated to the fluorophore FITC (diluted 1:100; Sigma, St. Louis, MO) was also used. After overnight incubation, primary antibody binding was visualized using fluorescent secondary antibodies (anti-rabbit IgG conjugated to Cy2 (1:200) or Cy5 (1:100) and anti-guinea pig IgG conjugated to Cy3 (1:200; Jackson ImmunoResearch, West Grove, PA). Tissue was washed twice in 0.1 m PB, incubated in secondary antibody for 2 hr at room temperature, washed twice in 0.1 m PB, and mounted on slides using DPX (Electron Microscopy Sciences, Ft. Washington, PA). Images were acquired using a 20× objective on a Leica confocal microscope. Under the sequential scanning mode, sections were scanned and images from three sections from each ganglion were acquired. The number of positively labeled cells for each marker and cells that had overlapping labeling were counted. The percentage of labeled cells and cells with overlapping labeling were compared using an un-paired t test with significance set at p ≤ 0.05. All statistical tests were performed after fulfillment of all necessary prerequisites using the Stat-View software package (Abacus Concepts, Berkeley, CA).
Ex vivo physiology preparation. The ex vivo cutaneous somatosensory system preparation has been described in detail previously (Woodbury et al., 2001). Briefly, adult mice were anesthetized via intramuscular injection of ketamine and xylazine (90 and 10 mg/kg, respectively) and perfused transcardially with oxygenated (95% O2-5% CO2) artificial CSF (aCSF; in mm: 1.9 KCl, 1.2 KH2PO4, 1.3 MgSO4, 2.4 CaCl2, 26.0 NaHCO3, and 10.0 d-glucose) with 253.9 mm sucrose at 12-15°C. The spinal cord, thoracic and upper lumbar DRGs, dorsal cutaneous nerves (DCNs), and dorsolateral trunk skin on one side were dissected and transferred to a separate recording chamber containing chilled oxygenated aCSF in which the sucrose was replaced with 127.0 mm NaCl. The preparation was pinned out with the epidermal surface of the skin facing upward and placed in a recording bath at 30-31°C for electrophysiological recording.
Sensory neuron somata were impaled with glass microelectrodes (>100 MΩ) containing 5-20% Neurobiotin (Vector Laboratories, Burlingame, CA) in 1 m potassium acetate. Electrical search stimuli were delivered through a suction electrode on the nerve to locate afferents with a peripheral process in the DCNs. Peripheral receptive fields were located with a blunt glass stylus.
Evoked activity was digitized on tape for subsequent off-line analyses. After physiological characterization, the cell was labeled by injecting Neurobiotin iontophoretically (one cell per DRG). Peripheral conduction velocity was calculated from spike latency and the distance between stimulating and recording electrodes (measured directly along the nerve). Heating responses were determined using a computer-controlled peltier device that delivered a 31-52°C heat ramp. The temperature 52°C was chosen as the maximal temperature because single units could be heated to this temperature repeatedly without apparent loss of function. Higher temperatures appeared to damage afferents, as evidenced by their inability to respond to a second heat ramp.
Tissue processing and analysis of recorded cells. Once a sensory neuron was characterized and filled with Neurobiotin, the DRG containing the injected cell was removed and immersion fixed (4% paraformaldehyde in 0.1 m PB for 30 min at 4°C). Ganglia were then blocked, embedded in 10% gelatin, postfixed, and cryoprotected in 20% sucrose overnight. Frozen sections (40-50 μm) were serially collected in PB and reacted with fluorescently-tagged avidin to label Neurobiotin-filled cells (Vector Laboratories). Next, each section was stained for either IB4 binding (Molecular Probes, Eugene, OR) or CGRP immunohistochemistry (Chemicon, Temecula, CA), TRPV1 immunohistochemistry (primary antibody generously provided by Dr. D. Julius), or TRPV2 immunohistochemistry (primary antibody provided by M.J.C.). In some cases, IB4 staining was combined with immunohistochemistry for CGRP, TRPV1, or TRPV2. All primary antibodies were prepared in rabbit. After incubation in primary antiserum, tissue was washed and incubated in goat anti-rabbit secondary antiserum (conjugated to Cy2, Cy3, or Cy5 and diluted 1:200; Molecular Probes). Distribution of fluorescent staining was determined using an Olympus confocal microscope and sequential scanning to prevent bleed-through of the different fluorophores.
Results
TRPV1 is present in a minority of mouse IB4-positive afferents
One explanation for the previous difference observed in rat and mouse with respect to the overlap of TRPV1 and IB4 staining is that the TRPV1 antibody used for analyzing mouse ganglia was directed against the N terminus of the rat TRPV1 sequence, which only overlaps 78% with the N terminus of mouse TRPV1. We therefore repeated this analysis using TRPV1 antibodies generated against a rat TRPV1 sequence (TRPV1R) and one generated against a mouse sequence of TRPV1 (TRPV1M).
The TRPV1M antiserum was made to the C terminus of mouse TRPV1, which differs from rat TRPV1 by a single amino acid (Ala in mouse vs Val in rat). Thus, both the C-terminus TRPV1M and the N-terminus TRPV1R were expected to produce similar staining patterns in rat DRG. Double immunolabeling of Sprague Dawley or Long-Evans rat L4/L5 ganglia showed that 98-99% of TRPV1R-positive neurons were also positive for TRPV1M (data not shown). Using the rat-specific antiserum, we found that 57 ± 3.2% of Sprague Dawley IB4-positive neurons and 48 ± 2.5% of Long-Evans IB4-positive neurons stained for TRPV1R (Fig. 1a-f), confirming the results of previous studies (Guo et al., 1999; Michael and Priestley, 1999).
In mouse, coexpression patterns were quite different from those observed in rat. Previously, using the rat-specific TRPV1R antiserum, we found only 2% of IB4-positive L4/L5 neurons were TRPV1 positive (Zwick et al., 2002). Using the more specific TRPV1M antibody, a slight increase in the percentage of TRPV1/IB4-positive neurons was detected. In the C3H/Bl6 mouse strain, 5.4 ± 1.4% of IB4-positive neurons were TRPV1M positive (Fig. 1g-i). Similarly, the DRG population in BALB/c mice expressed a low percentage (1.8 ± 0.3%) (Fig. 1j-l) of TRPV1M/IB4-positive neurons.
TRPV1-/- IB4-positive nociceptors have normal heat responses
To determine whether mouse IB4-positive sensory neurons require TRPV1 to exhibit normal heat responses, an ex vivo physiological preparation was used in which skin, DRG, and spinal cord from wild-type (C57BL/6) and TRPV1-/- mice (Caterina et al., 2000) were maintained in oxygenated aCSF. This preparation produces stable recordings from sensory neurons for up to 24 hr (Koerber and Woodbury, 2002; Woodbury and Koerber, 2003) while allowing mechanical and thermal stimulation of the skin and filling of neuronal somata with Neurobiotin for later neurochemical characterization (Fig. 2). Intracellular recordings were made from 33 wild-type (from 9 mice) and 41 TRPV1-/- (from 8 mice) C-fibers during a 21°C heat ramp (from 31 to 52°C). Nineteen of the 33 wild-type and 32 of 41 TRPV1-/- fibers exhibited a heat response (Fig. 3a-d) indicating that there was a small, but significant, increase in the percentage of heat-responsive C-fibers in TRPV-/- mice [57% (wild type) vs 78% (TRPV1-/-); Fisher's exact probability test; p = 0.05]. The mean threshold for firing of wild-type and TRPV1-/- neurons was not significantly different from wild-type mice for either the first or second spike in the heat response (first action potential: wild type, 43.1 ± 0.99°C; TRPV1-/-, 44.0 ± 0.85°C; second action potential: wild type, 44.7 ± 0.85°C; TRPV-/-, 45.8 ± 0.84°C). In addition, wild-type and TRPV1-/- neurons exhibit virtually identical frequency coding during the heat ramp (Fig. 4). These results are significantly different from previous recordings in TRPV1-/- mice using a skin nerve preparation that found that one-third of the normal number of cutaneous C-fibers responded to noxious heat, and those that responded had, on average, a 45% decrease in discharge rate (Caterina et al., 2000). Both the skin nerve and ex vivo preparation randomly sample primary afferents, and thus sample bias does not explain the difference in results. One potential contributing factor is that the skin nerve preparation involves recording from the saphenous nerve that innervates hairy skin of the hindlimb, whereas the ex vivo preparation was performed on backskin and its innervating DCNs.
Physiologically characterized C-fibers identified based on Neurobiotin labeling were stained for CGRP, TRPV1, TRPV2, or IB4. In wild-type mice, 7 of 10 heat-responsive C-mechanoreceptors were IB4 positive, whereas in TRPV1-/- mice, 11 of 14 cells were IB4 positive. That C-fibers innervating the skin are predominately IB4 positive has been reported previously by Lu et al. (2001), who showed 70% of epidermal fibers were IB4 positive and TrkA negative. Although we did not exhaustively test the neurochemical phenotype of the IB4-negative population in wild-type and TRPV1-/- mice, it is highly likely that they would have been peptidergic based on the consensus that the majority of nociceptors are either NGF [and express CGRP (Averill et al., 1995)] or GDNF [and express IB4 (Molliver et al., 1997)] dependent (Snider and McMahon, 1998). Moreover, there was no difference in the heat threshold of the IB4-negative cells compared with IB4-positive cells in wild-type or TRPV1-/- mice (wild-type mice: first action potential, 45.3 ± 2.04°C; second action potential, 46.3 ± 2.04; n = 3; TRPV1-/- mice: first action potential, 42 ± 3.5°C; second action potential, 43.6 ± 6.5°C; n = 3). These results suggest both IB4-negative (i.e., putative peptidergic neurons) and IB4-positive heat-responsive polymodal nociceptors were unaffected in their heat responses by the absence of TRPV1.
In TRPV1-/- mice, 12 of the heat-responsive C-fibers were incubated with anti-TRPV2 antiserum (Fig. 3e-g). Only one of these neurons was immunopositive for this putative heat channel, indicating that heat responses indistinguishable from those seen in wild-type mice could be recorded in the absence of TRPV1 or TRPV2.
Discussion
These studies were prompted by our inability to reconcile the lack of TRPV1 staining in IB4-positive mouse afferents (Zwick et al., 2002) with the extensive evidence that these neurons are a major population of cutaneous heat-responsive nociceptors (Averill et al., 1995; Molliver et al., 1995; Stucky and Lewin, 1999; Lu et al., 2001; Dirajlal et al., 2003). The results support the concept that normal heat responses are present in IB4-positive neurons in the absence of TRPV1 or TRPV2. We cannot rule out that the normal heat response seen in the TRPV1-/- mice was attributable to TRPV3. This seems unlikely, however, because TRPV3 appears to have a lower threshold for heat activation than TRPV1 (Smith et al., 2002; Benham et al., 2003). The threshold for TRPV3 is controversial, but even the highest observed value is 4-5°C below the threshold of the recordings seen in wild-type or TRPV1-/- mice. Second, TRPV3 shows dramatic sensitization to repeated heating (Smith et al., 2002), and this was never seen in our recordings from IB4-positive polymodal fibers. Finally, TRPV3 protein is colocalized with TRPV1 (at least in human) and has been proposed to exist as a heteromer (Smith et al., 2002). The lack of TRPV1 in mouse IB4-positive neurons suggests that TRPV3 is also not expressed in these cells.
The most compelling evidence that TRPV1 was the primary heat-responsive channel was that dissociated neurons from TRPV1-/- sensory ganglia exhibited no, or greatly attenuated, heat currents (Caterina et al., 2000; Davis et al., 2000). TRPV2 was considered a likely candidate for sensing temperatures above 52°C based on its similarity to TRPV1 and its ability to detect high heat stimuli in heterologous systems (Caterina et al., 2000; Davis et al., 2000). In either dissociated cell cultures or heterologous systems, sensory neurons (or their cell line equivalents) only approximate the intact neuron lacking normal central and peripheral processes and, in many aspects, are better models of axotomized neurons than of normal afferents. Thus, the most parsimonious explanation of the previous results and those presented here is that in normal intact mice (or at least in complete intact afferents, as is the case in the ex vivo preparation), at least two different mechanisms are present for detecting heat, a TRPV1-dependent and a TRPV1/2-independent mechanism. Our working hypothesis is that the TRPV1/2-independent mechanism is fully functional only when all portions of the afferent are present. The TRPV1/2-dependent mechanism becomes important after injury or in disease states and functions in isolated cells as seen in the knock-out studies. Supporting evidence that TRPV1 is not required for heat responses in intact animals is that in studies using TRPV1-/- mice, normal behavioral responses to noxious heat are measured, except at high temperatures that exceed those typically used to detect heat thresholds (Caterina et al., 2000; Davis et al., 2000; Moriyama et al., 2003). That TRPV1 is important in pathological states is further suggested by its ability to respond, and be potentiated by, multiple stimuli including those that are physical (heat and mechanical) and chemical (e.g., vanilloid compounds and acid). In addition, TRPV1 currents can be potentiated by interactions with G-coupled proteins like the bradykinin receptors (Shin et al., 2002; Sugiura et al., 2002; Carr et al., 2003; Ferreira et al., 2004) and the P2Y2 ATP receptor (Moriyama et al., 2003). It is also important to note that behavioral heat hyperalgesia induced by either complete Freund's adjuvant, carrageenan, or ATP is absent in TRPV1-/- mice (although pretreatment responses are normal) (Caterina et al., 2000; Davis et al., 2000; Moriyama et al., 2003). Finally, recent studies indicate that TRPV1 protein is increased in a p38 mitogen-activated protein kinase-dependent manner after inflammation (Ji et al., 2002). Thus, there is little doubt that TRPV1 is important for understanding the biology of pain. However, the present study shows that a major population of nociceptors (those that express IB4) use another mechanism under normal conditions to detect noxious heat and that this mechanism does not require the presence of functional TRPV1 or TRPV2.
Footnotes
This work was supported by National Institutes of Health Grants NS31826 (B.M.D.), NS33730 (K.M.A.), NS044094 (C.J.W.), and NS23725 (H.R.K.). We thank Dr. David Julius (University of California, San Francisco, San Francisco, CA) for the TRPV1M antibody, John Burkett (University of Kentucky, Lexington, KY) and Weiwen Wang (University of Pittsburgh, Pittsburgh, PA) for excellent technical assistance, and Patrick Crumrine (University of Kentucky) for statistical expertise.
Correspondence should be addressed to Dr. Brian M. Davis, Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Scaife Hall, Room S-843, 3550 Terrace Street, Pittsburgh, PA 15261. E-mail: bmd1{at}pitt.edu.
C. J. Woodbury's present address: Department of Zoology and Physiology, University of Wyoming, Laramie, WY 82071.
M. Zwick's present address: Department of Natural Sciences, Longwood University, Farmville, VA 23909.
Copyright © 2004 Society for Neuroscience 0270-6474/04/246410-06$15.00/0
↵* C.J.W. and M.Z. contributed equally to this work.